Hypervirulent Klebsiella pneumoniae: a call for consensus definition and international

Transcription

1 JCM Accepted Manuscript Posted Online 27 June 2018 J. Clin. Microbiol. doi: /jcm Copyright 2018 American Society for Microbiology. All Rights Reserved. 1 2 Hypervirulent Klebsiella pneumoniae: a call for consensus definition and international collaboration Sohei Harada, 1 Yohei Doi 1,2,3,4 1 Department of Infectious Diseases, 2 Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan 3 Division of Infectious Diseases, 4 Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

2 12 ABSTRACT 13 Hypervirulent Klebsiella pneumoniae strains have higher potential to cause more severe and 14 disseminated infections compared with classic K. pneumoniae strains. While initially reported from East Asian countries, cases have now been identified worldwide, sometimes in conjunction with extensive drug resistance. In this issue of the Journal of Clinical Microbiology, Russo et al. validated the diagnostic accuracy of biomarkers that differentiate hypervirulent K. pneumoniae strains from classic strains. This represents a major step forward in building a consensus definition and designing international studies aimed at elucidating the global epidemiology, clinical features and outcome of this important pathogen. Downloaded from on August 22, 2018 by guest

3 22 MAIN TEXT 23 Klebsiella pneumoniae infections are mainly been observed among hospitalized or 24 immunocompromised patients, but clinicians in Taiwan first recognized an increasing number of pyogenic K. pneumoniae infections occurring among community-residing individuals without apparent immunodeficiency other than diabetes mellitus or anatomical abnormalities in biliary tracts in the 1980s (1, 2). The most common presentation of such infections was liver abscess sometimes complicated by endophthalmitis and meningitis, but other invasive infections were also reported, including osteomyelitis and necrotizing fasciitis (3, 4). Fang and colleagues observed that most strains causing these pyogenic infections showed hypermucoviscosity when grown on agar plates and proposed the generation of viscous strings exceeding 5 mm between a colony and a loop as the diagnostic criterion, which is commonly referred to as the string test (5). These strains were much more resistant than classic K. pneumoniae to in vitro killing by serum or phagocytosis by neutrophils and macrophages and caused liver abscess and meningitis in mice, thus have also been referred to as hypervirulent K. pneumoniae (hvkp). The first gene identified as contributing to the hypermucoviscous phenotype in the representative strain NTUH-2044 was maga (mucoviscosity-associated gene A), which also conferred increased 38 virulence in mouse models (5). maga was later found to be identical to wzy_k1, which is part of the 39 capsule biosynthesis operon of strains belonging to capsule serotype K1, therefore serotype K1 was 40 recognized as the primary serogroup causing hvkp infections in Taiwan (1, 6). These serotype K1

4 41 strains are relatively monophyletic, belong to clonal group (CG) 23 predominated by sequence type 42 (ST) 23, and have since been reported frequently from East Asian countries besides Taiwan, 43 including South Korea, China and Japan (7-9) In addition to wzy_k1, several virulence factors have been identified that characterize the hypermucoviscous and hypervirulent phenotype in serotype K1 strains. They include the rmpa (regulator of mucoid phenotype A) genes and various siderophore genes. The prototypical hypermucoviscous K1 strain NTUH-2044 carries two rmpa genes ( p rmpa and p rmpa2) on the same large plasmid (pk2044), and another copy on the chromosomal integrative conjugative element (ICE) (10). Epidemiological comparison of the mucoviscous phenotype and rmpa carriage status among K. pneumoniae bacteremia strains in Taiwan has demonstrated significant correlation between them, and additionally identified hypermucoviscous strains with rmpa in serotypes other than K1 (11). On the other hand, rmpa/a2-positive, non-hypermucoviscous strains and rmpa/a2-negative, hypermucoviscous strains have also been found, suggesting the presence of yet other factors involved in the expression of the hypermucoviscous phenotype (12). Siderophores are important virulence factors that scavenge scarce ferric iron from the environment. In K. pneumoniae, aerobactin (encoded by iuc genes), salmochelin (encoded by iro genes) and yersiniabactin (encoded 57 by irp genes) are the representative siderophores. In the serotype K1 NTUH-2044 strain, the iuc and 58 iro genes are located on the same plasmid pk2044 as p rmpa and p rmpa2 genes (13). Among them, 59 the iuc genes appear to be critical in conferring accentuated virulence (14, 15). More recently, some

5 60 non-k1 K. pneumoniae strains, such as K2-ST86 and K2-ST380, have also been reported to cause 61 community-onset pyogenic infections (16, 17). These non-k1 hypervirulent strains are more clonally 62 diverse than K1-ST23 strains, but often carry pk2044-like plasmids encoding rmpa and iuc genes (13). Until recently, hvkp strains had relatively been susceptible to commonly used antimicrobial agents, with only a few exceptions including several strains producing extended-spectrum beta-lactamase (ESBL) (7). However, a hospital-based outbreak caused by a carbapenem-resistant, KPC-producing K. pneumoniae ST11 strain which had acquired a pk2044-like plasmid was recently reported from China (18). The strain was hypervirulent in vivo, and in fact caused high mortality among the infected patients. ST11 is the most common sequence type among KPC-producing K. pneumoniae in China and is considered to be a classical opportunistic K. pneumoniae clonal lineage in terms of virulence. Conversely, hypervirulent, antimicrobial-susceptible ST23 strains have also acquired bla KPC -encoding plasmids to become carbapenem-resistant (19). Thus, convergence of hypervirulence and multidrug resistance in K. pneumoniae, through both acquisition of resistance genes by hypervirulent strains and through acquisition of virulence genes by multidrug-resistant strains, poses a consequential public health challenge (20). 76 In this issue of the journal, Russo and colleagues set out to evaluate biomarkers that can accurately 77 differentiate hvkp and classical K. pneumoniae (ckp) (21). To do so, they first identified two sets of 78 strains: the hvkp-rich cohort, consisting of 85 clinical strains that caused pyogenic infection in

6 79 otherwise healthy outpatients in Taiwan and the U.S., 45 of which represented disseminated 80 infections including endophthalmitis and necrotizing fasciitis, and the ckp-rich cohort, including randomly selected bacteremia strains collected in the U.S., Canada and the U.K., under the assumption that hvkp strains would be extremely rare if existent at all in these countries. As a result, five of the ten virulence genes investigated (peg-344 [putative inner membrane transporter gene located on the same virulence plasmids (22)], irob, iuca, p rmpa, p rmpa2) showed a diagnostic accuracy of >0.95 in predicting strains in the hvkp-rich cohort. In addition, siderophore levels of 30 g/ml as measured by a quantitative assay had a diagnostic accuracy of The hypervirulence of the strains meeting these criteria was corroborated extensively in a murine sepsis model. On the other hand, the other attributes which have been associated with hvkp, including the typical capsule types (K1, K2, K5, K20, K54, K57) and the string test, had a lower diagnostic accuracy of 0.90 in predicting hvkp over ckp. The findings of this study have multiple implications for investigations of hvkp. Owing to the lack of a consensus definition of hvkp, studies have so far used various criteria (e.g., specific capsule types or a positive string test, alone or in combination) to define these strains. Because of this, whether a strain defined as hvkp in one study would also qualify as such in another study has been 95 unclear, which made interpretation and comparison of data challenging. If we can reach a consensus 96 definition of hvkp by incorporating genotypic or phenotypic biomarkers validated to achieve high 97 diagnostic accuracy in the present study, there will be multiple benefits to the research and clinical

7 98 community. First of all, the microbiological and clinical features of hvkp can be accumulated and 99 compared across different geographical areas. Second, early identification of hvkp infections may 100 inform clinicians, allowing them to conduct early and vigorous search for disseminated infection sites and potentially consider longer antimicrobial therapy compared with ckp infections. Clinical studies can be designed to determine whether such strategies can improve patient outcome. Third, improved definition of hvkp at the strain level will also facilitate investigation of the potential impact of these strains on hospitalized and immunocompromised patients. If hvkp is found to cause severe infections in these special populations, then infection control practices may need to be evaluated, to possibly implement contact precautions of carriers based on virulence rather than resistance. Finally, departure from the string test, which is intuitive and has served us well but has now shown to have less than optimal accuracy, will allow for more systematic investigations and identification of novel serotypes or clones of hvkp which may be circulating or may emerge in the future. The study by Russo and colleagues also identifies areas for further research. While comprehensive detection of peg-344, irob, iuca, p rmpa, and p rmpa2 is ideal, a typical clinical microbiology laboratory is not yet equipped to routinely perform such PCR-based tests. It is also not yet clear if 114 detection of one of the five genes with high diagnostic accuracy suffices or not. These genes often 115 exist on the same virulence plasmids thus detection of multiple genes may become redundant, but 116 genetic changes like deletion may alter the utility of each gene as a biomarker depending on which

8 117 specific strains are prevalent locally. For example, the KPC-producing hvkp strain that caused the 118 fatal outbreak in China possessed p rmpa2 but not p rmpa (18), and strains from China were not 119 included in this study. Detection of more than one gene may be a prudent approach for this reason The siderophore assay proposed in this work may be a reasonable substitute if the process can be simplified enough to be feasible in clinical laboratories, especially in endemic areas. Also, whether emerging hvkp serotypes and clones exert their virulent phenotype through the same sets of virulence factors remains unknown. Similar studies in different epidemiological contexts would be highly useful to see if these results can be replicated. In clinical practice, microbiologists and infectious diseases physicians have always inferred virulence of a microorganism based on the species identification and acted accordingly. However, if the approach to therapy can be individualized based on the predicted virulence of the specific infecting strain in addition to the species and antimicrobial susceptibility data to optimize clinical outcome, it could have significant impact on how we approach treatment of bacterial infections. The distinct clinical behavior of hvkp and ckp strains implies that it may be an ideal pathogen to explore such an approach, once we can come to a consensus on the definition of hypervirulence in K. pneumoniae. The present study sets the framework for this exciting possibility. Furthermore, having such a 133 common definition would facilitate designing and conduct of international studies aimed at 134 elucidating the global epidemiology and clinical features of this emerging pathogen. 135

9 136 Acknowledgments 137 We thank David Paterson for helpful discussion. Y. D. was supported by research grants from the 138 National Institutes of Health (R01AI104895, R21AI123747, R21AI135522) References 1. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 45: Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8: Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 16:e190-e Cheng NC, Yu YC, Tai HC, Hsueh PR, Chang SC, Lai SY, Yi WC, Fang CT Recent 152 trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae 153 necrotizing fasciitis. Clin Infect Dis 55: Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT A novel virulence gene in

10 155 Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic 156 complications. J Exp Med 199: Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 193: Zhang Y, Zhao C, Wang Q, Wang X, Chen H, Li H, Zhang F, Li S, Wang R, Wang H High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance. Antimicrob Agents Chemother 60: Chung DR, Lee HR, Lee SS, Kim SW, Chang HH, Jung SI, Oh MD, Ko KS, Kang CI, Peck KR, Song JH Evidence for clonal dissemination of the serotype K1 Klebsiella pneumoniae strain causing invasive liver abscesses in Korea. J Clin Microbiol 46: Harada S, Ishii Y, Saga T, Aoki K, Tateda K Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan. Diagn Microbiol Infect Dis doi: /j.diagmicrobio Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT The role of Klebsiella pneumoniae 171 rmpa in capsular polysaccharide synthesis and virulence revisited. Microbiology : Yu WL, Ko WC, Cheng KC, Lee HC, Ke DS, Lee CC, Fung CP, Chuang YC

11 174 Association between rmpa and maga genes and clinical syndromes caused by Klebsiella 175 pneumoniae in Taiwan. Clin Infect Dis 42: Lee CH, Liu JW, Su LH, Chien CC, Li CC, Yang KD Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: a prospective cross-sectional study in Taiwan. Int J Infect Dis 14:e Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. MBio 6:e Russo TA, Olson R, Macdonald U, Metzger D, Maltese LM, Drake EJ, Gulick AM Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun 82: Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect Immun 83: Decre D, Verdet C, Emirian A, Le Gourrierec T, Petit JC, Offenstadt G, Maury E, Brisse S, 190 Arlet G Emerging severe and fatal infections due to Klebsiella pneumoniae in two 191 university hospitals in France. J Clin Microbiol 49: Zhang Y, Sun J, Mi C, Li W, Zhao S, Wang Q, Shi D, Liu L, Ding B, Chang YF, Guo H, Guo

12 193 X, Li Q, Zhu Y First report of two rapid-onset fatal infections caused by a newly 194 emerging hypervirulent K. pneumoniae ST86 strain of serotype K2 in China. Front Microbiol 195 6: Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R, Chen S A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18: Zhang R, Lin D, Chan EW, Gu D, Chen GX, Chen S Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China. Antimicrob Agents Chemother 60: Chen L, Kreiswirth BN Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis 18: Russo TA, Olson R, Fang CT, Stoesser N, M. M, Macdonald U, Hutson A, Barker JH, La Hoz RM, Johnson JR, (HVKPIG) HKpIG Identification of biomarkers for the differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 56:e Bulger J, MacDonald U, Olson R, Beanan J, Russo TA Metabolite Transporter 209 PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain 210 hvkp1 after Pulmonary but Not Subcutaneous Challenge. Infect Immun 85:e